chrisvoncsefalvay/vaers-outcomes huggingface dataset:
second dose and is still feeling wonderful/feels wonderfull/"I don't ever feel this good"/I feel 20 years younger/; soreness at the injection site after second dose/soreness: worse on the second day, can still feel a little tiny bit when moving the arm, almost gone; pain at the injection site after second dose; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (second dose and is still feeling wonderful/feels wonderfull/"I don't ever feel this good"/I feel 20 years younger/), MYALGIA (soreness at the injection site after second dose/soreness: worse on the second day, can still feel a little tiny bit when moving the arm, almost gone) and VACCINATION SITE PAIN (pain at the injection site after second dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     Medical history was not provided by the reporter.  Concurrent medical conditions included Cramps, Coronary artery disease and Pain (before the vaccine). Concomitant products included AMLODIPINE BESILATE (NORVAC) for Coronary artery disease, OMEPRAZOLE for Stomach cramps, CLOPIDOGREL BISULFATE (PLAVIX) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.    On 05-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Oct-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (second dose and is still feeling wonderful/feels wonderfull/"I don't ever feel this good"/I feel 20 years younger/), MYALGIA (soreness at the injection site after second dose/soreness: worse on the second day, can still feel a little tiny bit when moving the arm, almost gone) and VACCINATION SITE PAIN (pain at the injection site after second dose). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (second dose and is still feeling wonderful/feels wonderfull/"I don't ever feel this good"/I feel 20 years younger/) outcome was unknown and MYALGIA (soreness at the injection site after second dose/soreness: worse on the second day, can still feel a little tiny bit when moving the arm, almost gone) and VACCINATION SITE PAIN (pain at the injection site after second dose) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was taking concomitant medications for cramps and coronary artery problems. No treatment medication were reported   This case was linked to MOD-2021-346776 (Patient Link).
March 3, 2021 Arm started itching,  Arm  has been sore for 3 days, warm to touch and swollen.  Rash appeared around injection site and below.  Size of rash 6" long x 3" across.  Applied ice throughout day and evening.  Found information online regarding COVID Arm reactions and pictures which looked like my rash. March 5, 2021 - rash is less but arm still swollen
Patient developed generalized itchiness and nausea 2 minutes after getting vaccine.  She has history of food , sulfa, cipro, fluconazole. No rash/hives. Vital signs BP 134/88, Pulse 108, Resp rate 24. EMS was notified and because one team was out transport 911 had to be called. She received epi pen from POD at 1:10AM in Left lateral thigh. VSS. A few minutes later still reported generalized itching and was given Benadryl 50mg PO tablet. FD paramedics on scene and administered IV benadryl, patient became nauseous and dry heaved. She was transported patient to Hospital in the village.
pt recv vax vax 17JUL96 & JUL96 pt exp lightheadedness & paresthesia while driving, frontal h/a & diminished appetite which persisted @ time of report;dx w/migraines;
Swelling; rash; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 42 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 42 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid prior vaccination: Yes" (unspecified if ongoing), notes: If Covid prior vaccination: Yes. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), when the patient was 42 years old, for COVID-19 immunization. The following information was reported: SWELLING (hospitalization) with onset 05Jan2022, outcome "unknown", described as "Swelling"; RASH (hospitalization) with onset 05Jan2022, outcome "unknown", described as "rash". The patient was hospitalized for swelling, rash (hospitalization duration: 3 day(s)). The events "swelling" and "rash" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. Therapeutic measures were taken as a result of swelling, rash. Clinical course: It was unknown if the patient received any other vaccine in four weeks and any other medication in 2 weeks.   The lot number for bnt162b2 was not provided and will be requested during follow up.
My covid symptoms started on 09/07/2021 and I only experienced a runny nose, and I had a report from a kid that goes to school with my kid that their kid tested positive so I had a rapid test and it was negative and on Tuesday I had another test and I got the results on the 09/11/2021.  My symptoms lasted probably for 7 days. The only other that showed up apart from the runny nose was a little light headedness. After 7 days it was gone. They did administer monoclonal antibodies. I had a fever for one day after the antibodies but that?s it.    I wanted to get advice on Humira--is it an immune suppressant drug? Did the vaccine work? Should I get a booster or not? Or Should I wait to get the booster? There?s no clarity. How about some information  on immunosuppressant drugs and their effect on the vaccine?
This spontaneous report as received from a pharmacy intern refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 17-AUG-2017, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 subcutaneously (dose, lot# and expiration date were not reported) for prophylaxis. There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 55 Fahrenheit degrees for 48 hours. Data logger was involved. There were no previous excursions reported.
Tachycardia (124), lightheaded, tremulous, dysphagia. Premedicated with Allegra 180mg  PO(9.45am). Pepcid 20mg  PO(1.30pm)., Tylenol 1g  PO (1.56pm). Observation for 1hr,  HR reduced to 92. Able to drink and swallow meds.  HA & lightheadedness resolved and mild dysphagia, HR 82 at 3.13pm.
a few hr p/vax pt exp paresthesia & pain in the inj arm;pt was treated w/codeine w/o results;by the next day pt exp paresthesia across the entire injected arm, including the fingers;pt has recovered;
passed out; could not breath; twitching of foot; extremely cold; became warm; upset stomach; room began to spin; unusually tired; A Spontaneous report was received from a health care professional concerning an female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced unusually tired, extremely cold, became warm, upset stomach, room began to spin, could not breath, pass out, twitching foot.  The patient's medical history, included cancer, prior radiation and chemotherapy and surgery. Concomitant product use included unspecified inhaler.   On 03 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (lot number 011az1a) intramuscularly for prophylaxis of COVID-19 infection.  On 03 Mar 2021, the same day of vaccination the patient was unusually tired and slept ten hours. Next day, the patient felt extreme cold and decided to take warm bath. Then within ten minutes after the bath, patient became warm, had an upset stomach, and noted the room began to spin. The patient subsequently could not breath and passed out.  The patient's husband noted the patient's foot twitching, and felt that she was still alive.  Per the patient's spouse, the patient was unresponsive for one minute.  Once awakened, the patient took her inhaler and Benadryl.  Within 30 minutes all the symptoms were gone and have not returned.  The patient noted having this same type of experience during her Sep 2020 first round of chemotherapy.  The patient has been cancer free for five months.  Treatment information included inhaler and Benadryl.  There was no change planned to the dosing schedule of mRNA-1273 in response to the events. Patient's physician stated it was okay to take the second dose.  The events unusually tired, extremely cold, became warm, upset stomach, room began to spin, could not breath, passed out, and twitching foot were considered resolved on 04 Mar 2021.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested
Information has been received from a physician concerning a 15 month old male who on 19-Sep-2003 was vaccinated with a dose of MMR virus vaccine live. It was unknown if the patient was on concomitant therapy. The patient's medical history was also unknown. On 22-Sep-2003 the patient developed hives. Medical attention was sought and the patient was treated with diphenhydramine hydrochloride (Benadryl). It was unknown if lab tests were performed. The hives lasted for 3 days. Subsequently, the patient recovered.
Uncontrollable screaming after vaccines. Fever 8/24. Fussy but consolable.
Metal taste immediately after injection.  8:20 felt hot and flushed.  blood pressure 118/78 heart rate 100.   8:32 b\p 130/80 Heart rate 100 discomfort in neck back and headache. Reported she had a headache with the first dose.  8:50 states she is better and ready to go home. b\p 128/88 heart rate 90 Advised to seek medical help if symptoms worsen.
Hard lump at injection site, then break out in chicken pox type lesions, widespread on body, still present 4 months later.
First dose no fever, shaking, freezing, nausea, achy, weak, tired. 24 hours then weak for 7 days and woke up drenched every time slept. 2 nd dose next day fever 104.6 , nausea, couldn?t eat or drink, body felt like hammer taken to it, joints hurt, throbbing pains in legs and feet, felt like ice water in  blood,  Sunday weak, dizzy, achy no fever, throat very sore, chest felt heavy, better by Sunday evening. Monday had to leave work broke out drenched in sweat, nausea, achy, extremely tired.
fatigue/feeling tired; achy; nausea; diarrhea; she's only eaten twice being vaccinated due to the diarrhea; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 16Feb2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On 16Feb2021, 2 hours after the vaccination, the patient had fatigue and hasn't "been able to get myself situated since then", feeling tired and achy along with nausea and diarrhea. She also noted "she's only eaten twice being vaccinated due to the diarrhea" in Feb2021. The events were considered as non-serious. The outcome of the events was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.
received all 3 vaccines from Moderna, and he did great on those vaccines except he felt sleepy; This spontaneous case was reported by a patient and describes the occurrence of SOMNOLENCE (received all 3 vaccines from Moderna, and he did great on those vaccines except he felt sleepy) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (received all 3 vaccines from Moderna, and he did great on those vaccines except he felt sleepy). At the time of the report, SOMNOLENCE (received all 3 vaccines from Moderna, and he did great on those vaccines except he felt sleepy) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2023-720960 (Patient Link).
VERY BAD ACHES; FEVER; CHILLS; HEADACHE; FELT WIPED OUT; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 2021, the subject experienced very bad aches. On 2021, the subject experienced fever. On 2021, the subject experienced chills. On 2021, the subject experienced headache. On 2021, the subject experienced felt wiped out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the very bad aches, fever, chills, headache and felt wiped out was not reported. This report was non-serious. This case, from the same reporter is linked to 20210424323.
Information has been received from a registered nurse concerning a 21 year old patient who on 10-NOV-2008 was vaccinated with a first dose of GARDASIL. Subsequently the patient experienced itching and redness at the injection site. On unknown date, the patient recovered from redness at the injection site. At the time of reporting, the patient's itching at the injection site persisted. The patient sought medical attention by contacting office. Additional information has been requested.
In December of 1999, the pt developed a "zoster-like rash" that was maculopapular and not vesicular. The rash was on the right side of the pt's back and extended to the pt's ribs. The pt had no fever. The rash was itchy and painful. The pt sought unspecified medical attention. Subsequently the pt recovered.
COVID arm; big red itchy rash on arm 2" in diameter at the injection site; itchy; injection site swelling; injection site redness; thirsty; This spontaneous case was reported by a consumer and describes the occurrence of THIRST (thirsty), INJECTION SITE PAIN (COVID arm), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE RASH (big red itchy rash on arm 2" in diameter at the injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A12A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced THIRST (thirsty), VACCINATION SITE SWELLING (injection site swelling) and VACCINATION SITE ERYTHEMA (injection site redness). On 13-Mar-2021, the patient experienced VACCINATION SITE RASH (big red itchy rash on arm 2" in diameter at the injection site) and VACCINATION SITE PRURITUS (itchy). On an unknown date, the patient experienced INJECTION SITE PAIN (COVID arm). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, THIRST (thirsty), INJECTION SITE PAIN (COVID arm), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE RASH (big red itchy rash on arm 2" in diameter at the injection site) and VACCINATION SITE PRURITUS (itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.
Thyroiditis subacute; Goitre; Headache; Odynophagia; Tenderness; Blood thyroid stimulating hormone increased; Thyroxine decreased; Triiodothyronine decreased; This is a spontaneous report from a non-contactable consumer. A contactable consumer reported different events for 29 patients. This is 10 of 29 reports.   A 55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. Medical history included diabetes mellitus, hypertension. No pharmacotherapy. Uncertain diagnosis. The patient's concomitant medications were not reported. The patient previously took codeine and experienced allergic reaction to codeine. On an unspecified date, the patient experienced thyroiditis subacute, blood thyroid stimulating hormone increased, goitre, headache, odynophagia, tenderness, thyroxine decreased, triiodothyronine decreased and SARS-CoV-2 test and results was unknown. Time to onset for the events for 4days. The outcome of events was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100974883 Same reporter/product and different patients/events
Severe pain in neck , shoulder and arm. Tingling started in fingertips and moved up hand to elbow.
PATIENT HAD SHOT ADMINISTERED AT ABOUT 10:30AM AND EXPERIENCED ADVERSE REACTIONS STARTING AT ABOUT 12:30PM. SHE SAID SHE HAD TROUBLE BREATHING AND A LOW GRADE FEVER.  SHE ALSO FELT AS THOUGH THERE WAS A LUMP IN HER THROAT. SHE WAITED FOR SYMPTOMS TO PASS THINKING THAT IT WAS DUE TO HER USUAL ALLERGIES WHICH SHE SAID CAN BE SEVERE AT TIMES.  ADVERSE REACTIONS PASSED AFTER ABOUT 4 HOURS DURING WHICH TIME SHE TOOK NO MEDICATIONS FOR.
ALT (ALANINE AMINOTRANSFERASE) LIVER ENZYMES WERE ELEVATED HIGHER THAN NORMAL ABOUT 152-153; This spontaneous report received from a patient concerned a 70 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: blood pressure abnormal. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1808609, and expiry: 07-SEP-2021) dose was not reported, administered on 06-APR-2021 15:00 for prophylactic vaccination. No concomitant medications were reported. On 01-SEP-2021, the patient experienced alt (alanine aminotransferase) liver enzymes were elevated higher than normal about 152-153. Laboratory data included: ALT increased (NR: not provided) ALT liver enzymes were elevated higher than normal about 152-153., and Blood test (NR: not provided) not reported. The action taken with covid-19 vaccine was not applicable. The outcome of alt (alanine aminotransferase) liver enzymes were elevated higher than normal about 152-153 was not reported. This report was non-serious.
SHE WAS ADMITTED FOR ACUTE COVID 19 INFECTION , RECEIVED X3 DAYS OF MONOCLONAL AB IV REMDISIVIR AND IMPROVED , SHE ALSO IS A KIDNEY TX PATIENT, SHE WAS DC HOME
Son shut down after  his last immunizations. He received them at 12 months and regressed at 14 months. Stopped talking; went into his own little world. Was diagnosed at 22 months PDD, but now they are saying he is severe.   The follow up states, "I do not have access to them." Annual follow up on 03/03/04: "Pt has not recovered from adverse events. He was fine up until 14 months he stopped talking and shut down and regressed and has never been the same.  He was developing fine until he get his last set of immunizations.
I gave  a 0.3mL dose of the purple cap Adult Pfizer Covid Vaccine to a 10.6 year old.
His entire left arm was completely numb; His mouth went completely numb; His tongue is having a tingling sensation; He has headache; His vision was blurred seeing very weird things; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer (patient).  A male patient of an unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number and expiration dates were not reported), via unspecified route of administration on 26Mar2021 in the left arm at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It reported that, patient received the 1st dose of vaccine on 26Mar2021 and due to take his 2nd shot on 16Apr2021. The patient stated on an unspecified date in Mar2021 last night his entire left arm was completely numb to touch down to his fingers and he couldn't feel the things that he is touching, his mouth went completely numb and his tongue was having a tingling sensation, headache and his vision was blurred seeing very weird things. The patient wanted to know if there was a report regarding this side effects after taking the vaccine. The outcome of the patient's events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
HEAD PRESSURE; ABDOMINAL PAIN; STUCK THROAT; DIZZINESS FOR APPROXIMATE HALF A  DAY BUT GONE ON THE NEXT DAY; NAUSEA; MILD HEADACHE; HALF OF MY HEAD TO THE NECK IS SO  STIFF AND GIVING HEADACHES AND  DIZZINESS; CHEST FELT LIKE A TIGHT SQUEEZE; HEAD FELT LIKE A TIGHT SQUEEZE,  COMPRESSION AND GIVING ME  HEADACHES; This spontaneous report received from a patient concerned a 44 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known drug allergies.  The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced half of my head to the neck is so stiff and giving headaches and dizziness. On APR-2021, the subject experienced chest felt like a tight squeeze. On APR-2021, the subject experienced head felt like a tight squeeze, compression and giving me headaches. On 06-APR-2021, the subject experienced head pressure. On 06-APR-2021, the subject experienced abdominal pain. On 06-APR-2021, the subject experienced stuck throat. On 06-APR-2021, the subject experienced dizziness for approximate half a day but gone on the next day. On 06-APR-2021, the subject experienced nausea. On 06-APR-2021, the subject experienced mild headache. On 03-MAY-2021, Laboratory data included: Blood test (NR: not provided) Not provided., Chest X-ray (NR: not provided) Not provided, EKG (NR: not provided) Not provided, and MRI (NR: not provided) Not provided. Treatment medications included: acetylsalicylic acid. The action taken with covid-19 vaccine was not applicable. The patient recovered from dizziness for approximate half a day but gone on the next day on 07-APR-2021, had not recovered from head pressure, abdominal pain, stuck throat, nausea, head felt like a tight squeeze, compression and giving me headaches, and half of my head to the neck is so stiff and giving headaches and dizziness, and the outcome of mild headache and chest felt like a tight squeeze was not reported. This report was non-serious.